EUVIMEDEUVIMED entdecken
Crossref

Decreased RNA ‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide

Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng iD, Fangfang Wang, Jingcao Huang und 4 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Zhimei Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Lenalidomide, Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Faculty Start Fund, Sichuan Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is an incurable plasma cell cancer in the bone marrow. Immunomodulatory drugs, such as lenalidomide (LEN) and pomalidomide, are backbone agents in MM treatment, and LEN resistance is commonly seen in the MM clinic. In this study, we presented that heterogeneous nuclear ribonucleoprotein U (hnRNPU) affected MM resistance to LEN via the regulation of target mRNA translation. hnRNPU Low MM cells exhibited upregulated CRBN and IKZF1 proteins, stringent IKZF1/3 protein degradation upon LEN addition and increased sensitivity to LEN. RNA pulldown assays and RNA electrophoretic mobility shift assays revealed that hnRNPU bound to the 3′‐untranslated region of CRBN and IKZF1 mRNA. A sucrose gradient assay suggested that hnRNPU specifically regulated CRBN and IKZF1 mRNA translation. The competition of hnRNPU binding to its target mRNAs by small RNAs with hnRNPU‐binding sites restored MM sensitivity to LEN. hnRNPU function in vivo was confirmed in an immunocompetent MM mouse model constructed by the inoculation of Crbn ‐humanized murine 5TGM1 cells into Crbn I391V/+ mice. Overall, this study suggests a novel mechanism of LEN sensitivity in which hnRNPU represses CRBN and IKZF1 mRNA translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LenalidomideMultiple MyelomaHumansMiceAnimalsAdaptor Proteins, Signal TransducingCell Line, TumorDrug Resistance, NeoplasmIkaros Transcription Factor

Stichwörter der Autor:innen

drug sensitivityhnRNPUlenalidomidemRNA translationmultiple myeloma

Substanzen

LenalidomideAdaptor Proteins, Signal TransducingIkaros Transcription Factor

Autor:innen und Institutionen

  • Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Hematology, The Affiliated Hospital of Chengdu University, Chengdu, China.
  • Department of Hematology, Mian-Yang Central Hospital, Mianyang, China.

ORCID-Profile: Yu Feng, Ting Niu, Yuhuan Zheng

Förderung

  • National Natural Science Foundation of China
  • Faculty Start Fund
  • Sichuan Natural Science Foundation
  • 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
  • Key Research and Development Program of Sichuan Province
  • National Key Research and Development Program of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Lin, Z., Zhang, Y., Liu, X., Luo, H., Li, Q., Gao, Q., Wang, X., Wen, J., Li, L., Feng, Y., Wang, F., Huang, J., Zhai, X., Zhang, L., Niu, T., & Zheng, Y. (2024). Decreased RNA ‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British Journal of Haematology. https://doi.org/10.1111/bjh.19468

Vancouver

Lin Z, Zhang Y, Liu X, Luo H, Li Q, Gao Q, et al. Decreased RNA ‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British Journal of Haematology. 2024. doi:10.1111/bjh.19468

BibTeX
@article{Lin2024,
  author = {Lin, Zhimei and Zhang, Yue and Liu, Xiang and Luo, Hongmei and Li, Qian and Gao, Qianwen and Wang, Xin and Wen, Jingjing and Li, Linfeng and Feng, Yu and Wang, Fangfang and Huang, Jingcao and Zhai, Xinyu and Zhang, Li and Niu, Ting and Zheng, Yuhuan},
  title = {Decreased RNA ‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19468}
}
Kostenlos starten →